Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-11-3
pubmed:abstractText
Calpains are calcium- and thiol-dependent proteases whose dysregulation has been implicated in a number of diseases and conditions such as cardiovascular dysfunction, ischemic stroke, and Alzheimer's disease (AD). While the effects of calpain activity are evident, the precise mechanism(s) by which dysregulated calpain activity results in cellular degeneration are less clear. In order to determine the impact of calpain activity, there is a need to identify the range of specific calpain substrates. Using an in vitro proteomics approach we confirmed that phosphatidylethanolamine-binding protein (PEBP) as a novel in vitro and in situ calpain substrate. We also observed PEBP proteolysis in a model of brain injury in which calpain is clearly activated. In addition, with evidence of calpain dysregulation in AD, we quantitated protein levels of PEBP in postmortem brain samples from the hippocampus of AD and age-matched controls and found that PEBP levels were approximately 20% greater in AD. Finally, with previous evidence that PEBP may act as a serine protease inhibitor, we tested PEBP as an inhibitor of the proteasome and found that PEBP inhibited the chymostrypsin-like activity of the proteasome by approximately 30%. Together these data identify PEBP as a potential in vivo calpain substrate and indicate that increased PEBP levels may contribute to impaired proteasome function.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-3042
pubmed:author
pubmed:issnType
Print
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1133-41
pubmed:dateRevised
2007-12-3
pubmed:meshHeading
pubmed-meshheading:17018026-Aged, pubmed-meshheading:17018026-Aged, 80 and over, pubmed-meshheading:17018026-Alzheimer Disease, pubmed-meshheading:17018026-Animals, pubmed-meshheading:17018026-Brain Injuries, pubmed-meshheading:17018026-Calpain, pubmed-meshheading:17018026-Cell Line, Tumor, pubmed-meshheading:17018026-Disease Models, Animal, pubmed-meshheading:17018026-Female, pubmed-meshheading:17018026-Hippocampus, pubmed-meshheading:17018026-Humans, pubmed-meshheading:17018026-Male, pubmed-meshheading:17018026-Mice, pubmed-meshheading:17018026-Nerve Degeneration, pubmed-meshheading:17018026-Phosphatidylethanolamine Binding Protein, pubmed-meshheading:17018026-Proteasome Endopeptidase Complex, pubmed-meshheading:17018026-Proteomics, pubmed-meshheading:17018026-Serine Proteinase Inhibitors
pubmed:year
2006
pubmed:articleTitle
Identification and characterization of PEBP as a calpain substrate.
pubmed:affiliation
Department of Gerontology, University of Kentucky, Lexington, Kentucky 40536, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural